Docosahexaenoic acid inhibits hepatic stellate cell activation to attenuate liver fibrosis in a PPARγ-dependent manner

被引:20
作者
He, Jianlin [1 ,2 ]
Hong, Bihong [1 ]
Bian, Mianli [2 ]
Jin, Huanhuan [2 ,3 ]
Chen, Junde [1 ]
Shao, Jiangjuan [2 ]
Zhang, Feng [2 ]
Zheng, Shizhong [2 ]
机构
[1] Minist Nat Resources, Inst Oceanog 3, Xiamen 361005, Fujian, Peoples R China
[2] Nanjing Univ Chinese Med, Sch Pharm, Dept Pharmacol, Nanjing 210029, Jiangsu, Peoples R China
[3] Wannan Med Coll, Sch Pharm, Dept Pharmacol, Wuhu 241000, Peoples R China
基金
中国国家自然科学基金;
关键词
Docosahexaenoic acid; Liver fibrosis; Peroxisome proliferator-activated receptor gamma; Molecular docking; Hepatic stellate cells; Ligand activation; POLYUNSATURATED FATTY-ACIDS; RECEPTOR-GAMMA; GENE-EXPRESSION; LIGAND; PDGF; N-3; TRANSREPRESSION; P21(WAF1/CIP1); TROGLITAZONE; P18(INK4C);
D O I
10.1016/j.intimp.2019.105816
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Docosahexaenoic acid (DHA) has been found to have a hepatoprotective effect. In this study, we investigated the role of peroxisome proliferator-activated receptor gamma (PPAR gamma) in DHA regulation of liver fibrosis. DHA was found to inhibit hepatic stellate cell (HSC)-LX2 cell viability and downregulate marker proteins of HSC activation. Furthermore, DHA induced cell cycle arrest at G1 phase in HSCs. Antagonism of PPAR gamma by GW9662 abrogated the effects of DHA on HSCs. Computer-aided molecular docking predicted that DHA bound to PPAR gamma via hydrogen bonding with residues Ser289, His323, Tyr473, and His499. We overexpressed Ser289 mutant PPAR gamma in HSC-LX2 cells and investigated fibrotic marker modulation, and found that DHA effects on HSCs were diminished. Thus, bonding with the Ser289 residue might be indispensable for DHA to activate PPAR gamma to exert its inhibiting effect on activated HSCs. Last, data from a CCl4-treated mouse model confirmed that PPAR gamma activation was required for DHA to attenuate liver fibrosis.
引用
收藏
页数:11
相关论文
共 54 条
[1]   PPAR-γ Agonists Induce Growth Arrest of Kit/AML1-ETO Leukemia Cells Acting on Diverse Pathways [J].
Agosti, Valter ;
Talarico, Daniela ;
Urzino, Agostina ;
Murthi, Raghavendra Vasudeva ;
Nocera, Aurora Anna Rita ;
Giovannone, Emilia Dora .
BLOOD, 2014, 124 (21)
[2]   Altered Hepatic Gene Expression in Nonalcoholic Fatty Liver Disease Is Associated With Lower Hepatic n-3 and n-6 Polyunsaturated Fatty Acids [J].
Arendt, Bianca M. ;
Comelli, Elena M. ;
Ma, David W. L. ;
Lou, Wendy ;
Teterina, Anastasia ;
Kim, TaeHyung ;
Fung, Scott K. ;
Wong, David K. H. ;
McGilvray, Ian ;
Fischer, Sandra E. ;
Allard, Johane P. .
HEPATOLOGY, 2015, 61 (05) :1565-1578
[3]   TGF-β signaling in fibrosis [J].
Biernacka, Anna ;
Dobaczewski, Marcin ;
Frangogiannis, Nikolaos G. .
GROWTH FACTORS, 2011, 29 (05) :196-202
[4]   Regulation of PDGF and its receptors in fibrotic diseases [J].
Bonner, JC .
CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (04) :255-273
[5]   Regression of Liver Fibrosis [J].
Campana, Lara ;
Iredale, John P. .
SEMINARS IN LIVER DISEASE, 2017, 37 (01) :1-10
[6]   Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation [J].
Carpino, G ;
Morini, S ;
Corradini, SG ;
Franchitto, A ;
Merli, M ;
Siciliano, M ;
Gentili, F ;
Muda, AO ;
Berloco, P ;
Rossi, M ;
Attili, AF ;
Gaudio, E .
DIGESTIVE AND LIVER DISEASE, 2005, 37 (05) :349-356
[7]   SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 [J].
Carrano, AC ;
Eytan, E ;
Hershko, A ;
Pagano, M .
NATURE CELL BIOLOGY, 1999, 1 (04) :193-199
[8]   Fish Omega-3 Fatty Acids Induce Liver Fibrosis in the Treatment of Bile Duct-Ligated Rats [J].
Chen, Chih-Cheng ;
Ho, Chun-Yi ;
Chaung, Hsio-Chi ;
Tain, You-Lin ;
Hsieh, Chih-Sung ;
Kuo, Fang-Ying ;
Yang, Chun-Yu ;
Huang, Li-Tung .
DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (02) :440-447
[9]   Dihydroartemisinin Prevents Liver Fibrosis in Bile Duct Ligated Rats by Inducing Hepatic Stellate Cell Apoptosis through Modulating the PI3K/Akt Pathway [J].
Chen, Qin ;
Chen, Lianyun ;
Wu, Xiafei ;
Zhang, Feng ;
Jin, Huanhuan ;
Lu, Chunfeng ;
Shao, Jiangjuan ;
Kong, Desong ;
Wu, Li ;
Zheng, Shizhong .
IUBMB LIFE, 2016, 68 (03) :220-231
[10]   Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats [J].
Chen, Wen-Ying ;
Lin, Shih-Yi ;
Pan, Hung-Chuan ;
Liao, Su-Lan ;
Chuang, Yu-Han ;
Yen, Yu-Ju ;
Lin, Szu-Yin ;
Chen, Chun-Jung .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2012, 23 (03) :252-264